Keyword search
Filter results by
Search HelpCurrently selected filters that can be removed
Remove Remove "Health" filterRemove Remove "Diseases and physical health conditions" filterRemove Remove "Canada" filterRemove Remove "Canadian COVID-19 Antibody and Health Survey (CCAHS)" filterRemove Remove "Sex, gender and sexual orientation" filter
Keyword(s)
Subject
Geography
3 facets displayed. 1 facets selected.
Survey or statistical program
1 facets displayed. 1 facets selected.
Results
All (3)
All (3) ((3 results))
- Table: 13-10-0867-01Geography: CanadaFrequency: OccasionalDescription: Long term symptoms were defined as having COVID-19 symptoms at least 3 months after a self-reported positive test or suspected SARS-CoV-2 infection. Results on the status of long-term symptoms only included respondents for whom a period of three months separated their self-reported date of infection and the date they completed the questionnaire.Release date: 2023-08-03
- Table: 13-10-0868-01Geography: Canada, Geographical region of Canada, Province or territoryFrequency: OccasionalDescription: This survey provides new evidence about those who indicated on their electronic questionnaire a positive test result with either a positive polymerase chain reaction (PCR) test or a rapid antigen test (RAT), as well as those who suspected that they had an infection. These results are based on the individual's self-reported first positive test result or first suspected infection and does not account for multiple infections.Release date: 2023-08-03
- Table: 13-10-0866-01Geography: Canada, Geographical region of Canada, Province or territoryFrequency: OccasionalDescription: Dried blood spot testing was used to detect antibodies against SARS-CoV-2, the virus that causes COVID-19. The proportion of Canadians who have antibodies from infection is referred to as the seroprevalence of SARS-CoV-2.Release date: 2023-03-27
Data (3)
Data (3) ((3 results))
- Table: 13-10-0867-01Geography: CanadaFrequency: OccasionalDescription: Long term symptoms were defined as having COVID-19 symptoms at least 3 months after a self-reported positive test or suspected SARS-CoV-2 infection. Results on the status of long-term symptoms only included respondents for whom a period of three months separated their self-reported date of infection and the date they completed the questionnaire.Release date: 2023-08-03
- Table: 13-10-0868-01Geography: Canada, Geographical region of Canada, Province or territoryFrequency: OccasionalDescription: This survey provides new evidence about those who indicated on their electronic questionnaire a positive test result with either a positive polymerase chain reaction (PCR) test or a rapid antigen test (RAT), as well as those who suspected that they had an infection. These results are based on the individual's self-reported first positive test result or first suspected infection and does not account for multiple infections.Release date: 2023-08-03
- Table: 13-10-0866-01Geography: Canada, Geographical region of Canada, Province or territoryFrequency: OccasionalDescription: Dried blood spot testing was used to detect antibodies against SARS-CoV-2, the virus that causes COVID-19. The proportion of Canadians who have antibodies from infection is referred to as the seroprevalence of SARS-CoV-2.Release date: 2023-03-27
Analysis (0)
Analysis (0) (0 results)
No content available at this time.
Reference (0)
Reference (0) (0 results)
No content available at this time.
- Date modified: